Role of mitogen-activated protein kinase kinase kinases in signal integration

被引:0
作者
B D Cuevas
A N Abell
G L Johnson
机构
[1] University of North Carolina School of Medicine,Department of Pharmacology and Lineberger Comprehensive Cancer Center
来源
Oncogene | 2007年 / 26卷
关键词
MAPK kinase kinases; MKKKs; signaling hubs;
D O I
暂无
中图分类号
学科分类号
摘要
Mitogen-activated protein kinases (MAPKs) are members of a dynamic protein kinase network through which diverse stimuli regulate the spatio-temporal activities of complex biological systems. MAPKs regulate critical cellular functions required for homeostasis such as the expression of cytokines and proteases, cell cycle progression, cell adherence, motility and metabolism. MAPKs therefore influence cell proliferation, differentiation, survival, apoptosis and development. In vertebrates, five MAPK families are regulated by MAPK kinase kinase-MAPK kinase-MAPK (MKKK-MKK-MAPK) phosphorelay systems. There are at least 20 MKKKs that selectively phosphorylate and activate different combinations of the seven MKKs, resulting in a specific activation profile of members within the five MAPK families. MKKKs are differentially activated by upstream stimuli including cytokines, antigens, toxins and stress insults providing a mechanism to integrate the activation of different MAPKs with the cellular response to each stimulus. Thus, MKKKs can be considered as ‘signaling hubs’ that regulate the specificity of MAPK activation. In this review, we describe how the MKKK ‘hub’ function regulates the specificity of MAPK activation, highlighting MKKKs as targets for therapeutic intervention in cancer and other diseases.
引用
收藏
页码:3159 / 3171
页数:12
相关论文
共 468 条
  • [31] Dedi N(2006)Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway Semin Oncol 33 392-549
  • [32] Long JM(2001)Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway Cancer Res 61 538-4286
  • [33] Dunster NJ(2001)Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics J Biol Chem 276 4276-1107
  • [34] Cheetham GM(2006)Identification and characterization of a novel MAP kinase kinase kinase, MLTK Microbes Infect 8 1098-1148
  • [35] Camarero G(2004)The ASK1-MAP kinase pathways in immune and stress responses J Clin Invest 113 1138-1552
  • [36] Tyrsin OY(2004)Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure FASEB J 18 1550-103
  • [37] Xiang C(2004)Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease Nat Immunol 5 98-28632
  • [38] Pfeiffer V(1998)Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3 J Biol Chem 273 28625-32722
  • [39] Pleiser S(1997)Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades J Biol Chem 272 32719-94
  • [40] Wiese S(1997)Regulation of cell migration by the calcium-dependent protease calpain Science 275 90-164